Preventive medicine service that combines blood tests on 115+ biomarkers, AI and assigned primary care physicians.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Pre Seed UK-based Emerald added $1.2 million to its pre-seed ($2 million total) led by Boost Capital Partners for its service combining blood testing, AI and medical care. | $1.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.